Novakind Pharma Private Limited
About Novakind Pharma Private Limited
Data last updated:
Novakind Pharma Private Limited is a private limited company based in Ratlam, Madhya Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2019PTC048375. Its GSTIN is 23AAGCN4991C1ZJ (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.2 Lakh. It is led by directors Aditya Chawda (Managing Director) and Kanhaiya Lal Patidar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 67 Badawada Tehsil Jaora, Ratlam, Madhya Pradesh, India – 457226.
As per the financials filed for FY 2024, the company reported a revenue of ₹33,554. For the same year it recorded a net loss of ₹1,414 (net margin -4.2%) and EBITDA of ₹4,553 (EBITDA margin 13.6%). Revenue has declined at a compounded annual rate (CAGR) of 65% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address67 Badawada Tehsil Jaora, Ratlam, Madhya Pradesh, India – 457226
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Novakind Pharma Private Limited
The main business activity of Novakind Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Novakind Pharma Private Limited FY 2025 filings available
Novakind Pharma Private Limited reported revenue of ₹33,554 for FY 2024.
Compounded Annual Growth Rate (CAGR) of Novakind Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 65% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Novakind Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4,553 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1,414 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Novakind Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Novakind Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Novakind Pharma Private Limited
Novakind Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eco Sparckle Private Limited | ₹33,617 (FY 2025) | •••• | •••• | -98.0% | •••• | Bangalore, Karnataka, India |
| Cygnus Barter Private Limited | ₹33,600 (FY 2025) | •••• | •••• | 6.0% | •••• | Howrah, West Bengal, India |
| Frontline Vintrade Private Limited | ₹33,600 (FY 2025) | •••• | •••• | 45.0% | •••• | Durg, Chhattisgarh, India |
| Premiobizz Private Limited | ₹33,598 (FY 2023) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Omshiva Industries Private Limited | ₹33,560 (FY 2024) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Novakind Pharma Private Limited this company | ₹33,554 (FY 2024) | •••• | •••• | •••• | Ratlam, Madhya Pradesh, India | |
| Velocity Infradevelopers Private Limited | ₹33,550 (FY 2025) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Moulimani Impex Private Limited | ₹33,543 (FY 2024) | •••• | •••• | 347.0% | •••• | Mira Road, Maharashtra, India |
| Valor Vape Distributions (OPC) Private Limited | ₹33,542 (FY 2020) | •••• | •••• | •••• | Gurgaon, Haryana, India | |
| Yummy Nutrie Foods Private Limited | ₹33,511 (FY 2024) | •••• | •••• | 333.0% | •••• | Surat, Gujarat, India |
| Safeline Vinimay Private Limited | ₹33,510 (FY 2025) | •••• | •••• | 8.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Novakind Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Novakind Pharma Private Limited
Novakind Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanhaiya Lal Patidar | Director | 16 Apr 2019 | 7 Years 5 Months | Current |
| Aditya Chawda | Managing Director | 16 Apr 2019 | 7 Years 5 Months | Current |
Ownership and Shareholding of Novakind Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Novakind Pharma Private Limited
Novakind Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Novakind Pharma Private Limited
Employment history and EPFO contributions of people linked to Novakind Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Novakind Pharma Private Limited
Novakind Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Nitesh ceased to be Director on 22 Nov 2019.
Credit Ratings, Litigation & Regulatory Alerts for Novakind Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Novakind Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Novakind Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Novakind Pharma Private Limited
Novakind Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAGCN4991C1ZJ | Madhya Pradesh | Active | 07 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Novakind Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novakind Pharma Private Limited
Novakind Pharma is an active private limited company based in Ratlam, Madhya Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 16 April 2019 (7+ years old) and is registered under CIN U51909MP2019PTC048375.
Novakind Pharma reported revenue of ₹33,554 for FY 2024.
Novakind Pharma has 2 current directors:
- Aditya Chawda - Managing Director
- Kanhaiya Lal Patidar - Director
Novakind Pharma reported a net loss of ₹1,414 (net margin -4.2%) and EBITDA of ₹4,553 (EBITDA margin 13.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Novakind Pharma is -65% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Novakind Pharma is 23AAGCN4991C1ZJ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Novakind Pharma is U51909MP2019PTC048375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novakind Pharma was incorporated on 16 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Novakind Pharma by revenue are Eco Sparckle Private Limited, Cygnus Barter Private Limited, Frontline Vintrade Private Limited, Premiobizz Private Limited, Omshiva Industries Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Nitesh ceased to be Director on 22 Nov 2019. Aditya Chawda was appointed as Managing Director on 16 Apr 2019. Kanhaiya Lal Patidar was appointed as Director on 16 Apr 2019.
The registered office of Novakind Pharma is at 67 Badawada Tehsil Jaora, Ratlam, Madhya Pradesh, India – 457226.